Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Carlyle (CG) Asset Writedowns and Impairment (2021 - 2022)

Carlyle has reported Asset Writedowns and Impairment over the past 2 years, most recently at -$26.8 million for Q4 2022.

For Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to -$26.8 million; the TTM value through Dec 2022 reached -$26.8 million, down 200.0%, while the annual FY2021 figure was $26.8 million, N/A changed from the prior year.
Asset Writedowns and Impairment for Q4 2022 was -$26.8 million at Carlyle, down from $26.8 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $26.8 million in Q2 2021 and troughed at -$26.8 million in Q4 2022.